Latest news with #Hipec

Time of India

KGMU's Hipec offers affordable hope for advanced cancer patients

Lucknow: In a beacon of hope for patients, King George's Medical University ( KGMU ) has started offering hyperthermic intraperitoneal chemotherapy (Hipec) for those suffering from advanced abdominal malignancies . This will allow Uttar Pradesh residents to access this treatment locally, reducing the need to travel to major cities like Delhi or Mumbai. The procedure is offered at a significantly lower cost of Rs 30,000, compared to Rs 5-8 lakh in private hospitals. The highly specialised procedure is being performed in the surgical oncology department of the university. In the first month alone, eight patients — including seven women with ovarian cancer and one with colon cancer — successfully underwent Hipec at the institute. According to officials, Hipec is a complex and resource-intensive surgery that requires advanced machines, a skilled surgical team and intensive post-operative care. "The surgery involves delivering heated chemotherapy drugs directly into the abdominal cavity during surgery. For this, specialised equipment and experienced staff are essential, and such setups were earlier limited to a few high-end private hospitals in Delhi and Mumbai," said Dr Naseem Akhtar of the surgical oncology department. Setting up Hipec at a govt institution like KGMU required detailed planning, funding and specialised training. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No.1 Swing Trading Strategy Revealed by Mr. Hemant – Free Access! TradeWise Learn More Undo Only after extensive preparation and capacity-building was the university able to offer this service at a highly subsidised rate. Dr Akhtar explained, "Hipec is a unique form of heated chemotherapy delivered directly into the abdominal cavity during surgery. This allows the drugs to penetrate and destroy cancer cells more effectively than conventional chemotherapy." Dr Vijay Kumar, head of the department, said, "It enables complete removal of infected tissues in cancers of the colon, rectum, and ovaries. The success rate here is significantly high."